These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37786340)

  • 1. Consensus recommendations on the use of injectable poly-l-lactic acid in Asian patients.
    Avelar L; Ong A; Ong D; Wai ACS; Wai AYT; Sungkyu J; Seok LH; Tam E; Leng SE; Huang J; Chao Y; Bråsäter D; Prygova I
    J Cosmet Dermatol; 2023 Dec; 22(12):3223-3231. PubMed ID: 37786340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization.
    Vleggaar D; Fitzgerald R; Lorenc ZP; Andrews JT; Butterwick K; Comstock J; Hanke CW; O'Daniel TG; Palm MD; Roberts WE; Sadick N; Teller CF
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s44-51. PubMed ID: 24719078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for restoration of soft tissue volume.
    Schierle CF; Casas LA
    Aesthet Surg J; 2011 Jan; 31(1):95-109. PubMed ID: 21239677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring.
    Lam SM; Azizzadeh B; Graivier M
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):55S-63S. PubMed ID: 16936545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term aesthetic outcomes with injectable poly-l-lactic acid: observations and practical recommendations based on clinical experience over 5 years.
    Rendon MI
    J Cosmet Dermatol; 2012 Jun; 11(2):93-100. PubMed ID: 22672273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert Recommendations on the Use of Injectable Poly-L-lactic Acid for Contour Deficiencies of the Buttocks.
    Harper J; Avelar L; Haddad A; Novello J; Mest D; Guarnieri-Munia C; Rice S; Vega J; Andriopolous B; Nogueria A; Sadick N
    J Drugs Dermatol; 2022 Jan; 21(1):21-26. PubMed ID: 35005870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decade of experience with injectable poly-L-lactic acid: a focus on safety.
    Bartus C; William Hanke C; Daro-Kaftan E
    Dermatol Surg; 2013 May; 39(5):698-705. PubMed ID: 23379657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate selection and application of nonsurgical facial rejuvenation agents and procedures: panel consensus recommendations.
    Fitzgerald R; Graivier MH; Kane M; Lorenc ZP; Vleggaar D; Werschler WP; Kenkel JM
    Aesthet Surg J; 2010; 30 Suppl():36S-45S. PubMed ID: 20844300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for the use of injectable poly-L-lactic acid in people of color.
    Hamilton TK; Burgess CM
    J Drugs Dermatol; 2010 May; 9(5):451-6. PubMed ID: 20480787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soft-tissue augmentation and the role of poly-L-lactic acid.
    Vleggaar D
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):46S-54S. PubMed ID: 16936544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The history behind the use of injectable poly-L-lactic acid for facial and nonfacial volumization: the positive impact of evolving methodology.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s32-4. PubMed ID: 24719075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European expert recommendations on the use of injectable poly-L-lactic acid for facial rejuvenation.
    Alessio R; Rzany B; Eve L; Grangier Y; Herranz P; Olivier-Masveyraud F; Vleggaar D
    J Drugs Dermatol; 2014 Sep; 13(9):1057-66. PubMed ID: 25226006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "skinny"on Sculptra: a practical primer to volumization with poly-L-lactic acid.
    Palm M; Chayavichitsilp P
    J Drugs Dermatol; 2012 Sep; 11(9):1046-52. PubMed ID: 23135646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience.
    Butterwick K; Lowe NJ
    J Am Acad Dermatol; 2009 Aug; 61(2):281-93. PubMed ID: 19615539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations on the Use of Injectable Poly-L-Lactic Acid for Skin Laxity in Off-Face Areas.
    Haddad A; Menezes A; Guarnieri C; Coimbra D; Ribeiro E; Sarubi J; Avelar LE; Del Nero MP; da Cunha MG; Mazzuco R; Kamamoto C; Cazerta C
    J Drugs Dermatol; 2019 Sep; 18(9):929-935. PubMed ID: 31524350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing facial rejuvenation outcomes by combining poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and neurotoxins: two case studies.
    Lorenc ZP; Daro-Kaftan E
    J Drugs Dermatol; 2014 Feb; 13(2):191-5. PubMed ID: 24509971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satisfying patient expectations with poly-L-lactic acid soft tissue augmentation.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s40-3. PubMed ID: 24719077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly-L-lactic acid: a new dimension in soft tissue augmentation.
    Rotunda AM; Narins RS
    Dermatol Ther; 2006; 19(3):151-8. PubMed ID: 16784514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimizing adverse events associated with poly-L-lactic acid injection.
    Narins RS
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S100-4. PubMed ID: 18547172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need for consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s28. PubMed ID: 24719073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.